UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 10-Q

              [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                  For the Quarterly Period Ended June 30, 2001

                                       OR

              [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                   For the transition period from ____ to ____

                        Commission File Number 000-18799
                                              -----------


                       HEALTH MANAGEMENT ASSOCIATES, INC.
             ------------------------------------------------------
             (Exact name of Registrant as specified in its charter)

          DELAWARE                                         61-0963645
 --------------------------------                 ----------------------------
 (State or other jurisdiction                          (I.R.S. Employer
 of incorporation or organization)                     Identification Number)

    5811 Pelican Bay Boulevard, Suite 500, Naples, Florida         34108-2710
 ---------------------------------------------------------       --------------
   (Address of principal executive offices)                        (Zip Code)

                                 (941)598-3131
             ----------------------------------------------------
             (Registrant's telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months, and (2) has been subject to such filing requirements
for the past 90 days.
                                                           Yes  X   No ___
                                                               ---

At August 9, 2001, the following shares of the Registrant were outstanding:


          Class A Common Stock   245,181,077 shares


                       HEALTH MANAGEMENT ASSOCIATES, INC.
                                    FORM 10-Q
                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2001


                                 INDEX
                                 -----


PART I.  FINANCIAL INFORMATION                                        Page

Item 1.  Financial Statements

     Consolidated Statements of Income--
      Three Months Ended June 30, 2001 and 2000......................  3

     Consolidated Statements of Income--
      Nine Months Ended June 30, 2001 and 2000.......................  4

     Condensed Consolidated Balance Sheets--
       June 30, 2001 and September 30, 2000..........................  5

     Condensed Consolidated Statements of Cash Flows--
       Nine Months Ended June 30, 2001 and 2000......................  6

     Notes to Interim Condensed Consolidated Financial Statements....  7-8

Item 2.  Management's Discussion and Analysis of Financial
          Condition and Results of Operations........................  9-13

PART II. OTHER INFORMATION...........................................  14

Signatures...........................................................  15

Index To Exhibits....................................................  16-17

                                       2


PART I.  FINANCIAL INFORMATION
Item 1.  Financial Statements


                       HEALTH MANAGEMENT ASSOCIATES, INC.

                        CONSOLIDATED STATEMENTS OF INCOME
                    (In thousands, except per share amounts)
                                   (Unaudited)


                                                     Three months ended
                                                          June 30,
                                                     ------------------
                                                       2001      2000
                                                     --------  --------

Net patient service revenue........................  $473,203  $391,099

Costs and expenses:
 Salaries and benefits.............................   176,279   134,579
 Supplies and other................................   133,995   114,508
 Provision for doubtful accounts...................    36,158    34,353
 Depreciation and amortization.....................    22,876    19,094
 Rent expense......................................    10,239     9,660
 Interest, net.....................................     4,500     6,767
                                                     --------  --------
  Total costs and expenses.........................   384,047   318,961
                                                     --------  --------

Income before income taxes.........................    89,156    72,138

Provision for income taxes.........................    35,018    28,315
                                                     --------  --------


Net income.........................................  $ 54,138   $ 43,823
                                                     ========   ========


Net income per share:
 Basic...........................................    $    .22   $    .18
                                                     ========   ========
 Diluted.........................................    $    .21   $    .18
                                                     ========   ========


Weighted average number of shares outstanding:
 Basic...........................................     245,048    242,078
                                                     ========   ========
 Diluted ........................................     264,305    245,917
                                                     ========   ========




                            See accompanying notes.

                                       3


                       HEALTH MANAGEMENT ASSOCIATES, INC.

                        CONSOLIDATED STATEMENTS OF INCOME
                    (In thousands, except per share amounts)
                                   (Unaudited)


                                                         Nine months ended
                                                               June 30,
                                                      ----------------------
                                                         2001        2000
                                                      ----------  ----------

Net patient service revenue........................   $1,388,584  $1,169,848

Costs and expenses:
   Salaries and benefits...........................      522,952     414,186
   Supplies and other..............................      395,730     339,637
   Provision for doubtful accounts.................      105,114     101,411
   Depreciation and amortization...................       66,422      55,760
   Rent expense....................................       30,015      28,202
   Interest, net...................................       15,808      18,960
   Non-cash charge for retirement benefits
     and write down of assets held for sale........       17,000           -
                                                      ----------  ----------
       Total costs and expenses....................    1,153,041     958,156
                                                      ----------  ----------

Income before income taxes.........................      235,543     211,692

Provision for income taxes.........................       92,487      83,090
                                                      ----------  ----------


Net income ........................................   $  143,056  $  128,602
                                                      ==========  ==========



Net income per share:
 Basic.............................................   $      .59  $      .53
                                                      ==========  ==========
 Diluted...........................................   $      .56  $      .53
                                                      ==========  ==========


Weighted average number of shares outstanding:
 Basic.............................................      244,130     241,720
                                                      ==========  ==========
 Diluted...........................................      264,000     244,874
                                                      ==========  ==========




                             See accompanying notes.

                                       4


                       HEALTH MANAGEMENT ASSOCIATES, INC.
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                 (In thousands)



                                                     June 30,     September 30,
                                                       2001            2000
                         ASSETS                    -----------     -----------
                         ------                    (Unaudited)
Current assets:
 Cash and cash equivalents.......................  $   49,649      $   16,471
 Receivables--net................................     375,589         372,653
 Supplies, prepaids and other assets.............      66,803          57,866
 Funds held by trustee...........................       3,041           2,562
 Deferred income taxes...........................      37,411          37,411
                                                   ----------      ----------
   Total current assets..........................     532,493         486,963

Property, plant and equipment....................   1,439,313       1,352,819
 Less accumulated depreciation and amortization..    (344,895)       (287,489)
                                                   ----------      ----------
   Net property, plant and equipment.............   1,094,418       1,065,330

Other assets:
 Funds held by trustee...........................       1,942           2,005
 Excess of cost over acquired net assets, net....     229,962         195,004
 Deferred charges and other assets...............      22,322          22,763
                                                   ----------      ----------
   Total.........................................     254,226         219,772
                                                   ----------      ----------

                                                   $1,881,137      $1,772,065
                                                   ==========      ==========

    LIABILITIES AND STOCKHOLDERS' EQUITY
    ------------------------------------

Current liabilities:
 Accounts payable................................  $   90,180      $   78,227
 Accrued expenses and other liabilities..........      77,751          82,910
 Income taxes--currently payable and deferred....       1,931           2,122
 Current maturities of long-term debt............       6,669           6,523
                                                   ----------      ----------
   Total current liabilities.....................     176,531         169,782

Deferred income taxes............................      27,896          34,496
Other long-term liabilities......................      35,124          17,570
Long-term debt...................................     448,057         520,151

Stockholders' equity:
 Preferred stock, $.01 par value, 5,000
  shares authorized..............................           -               -
 Common stock, Class A, $.01 par value, 750,000
  shares authorized, 257,606 and 255,357
  shares issued and outstanding at June 30,
  2001 and September 30, 2000, respectively......       2,576           2,554
 Additional paid-in capital......................     329,219         308,834
 Retained earnings...............................     973,225         830,169
                                                   ----------      ----------
                                                    1,305,020       1,141,557
 Less treasury stock, 12,500 shares at cost......    (111,491)       (111,491)
                                                   ----------      ----------
   Total stockholders' equity....................   1,193,529       1,030,066
                                                   ----------      ----------

                                                   $1,881,137      $1,772,065
                                                   ==========      ==========


                             See accompanying notes.

                                       5


                       HEALTH MANAGEMENT ASSOCIATES, INC.
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (In thousands)
                                   (Unaudited)

                                                            Nine months ended
                                                                 June 30,
                                                         ---------------------
                                                           2001        2000
                                                           ----        ----
Cash flows from operating activities:
 Net income...........................................  $ 143,056   $ 128,602
 Adjustments to reconcile net income to net
  cash provided by operating activities:
   Depreciation and amortization......................     66,422      55,760
   Provision for doubtful accounts....................    105,114     101,411
   Loss on sale of fixed assets.......................         10          31
   Charges for retirement benefits
    and write down of assets held for sale............     17,000           -

   Changes in assets and liabilities:
    Receivables.......................................   (104,568)   (109,928)
    Supplies and other current assets.................     (8,337)    (11,407)
    Deferred charges and other assets.................     (5,863)    (13,528)
    Accounts payable..................................     11,953      (2,033)
    Accrued expenses and other liabilities............     (6,028)        829
    Income taxes--
     currently payable and deferred...................       (191)    (18,108)
    Other long term liabilities.......................     (5,986)        816
                                                        ---------   ---------

      Net cash provided by operating activities .         212,582     132,445
                                                        ---------   ---------

Cash flows from investing activities:
 Acquisition of facilities, net of cash acquired......    (60,198)    (55,603)
 Additions to property, plant and equipment...........    (67,178)    (87,266)
 Proceeds from sale of property, plant and equipment        2,929         149
                                                        ---------   ---------

      Net cash used in investing activities...........   (124,447)   (142,720)
                                                        ---------   ---------

Cash flows from financing activities:
 Proceeds from long-term borrowings...................     27,958     103,214
 Principal payments on debt...........................   (102,905)    (50,925)
 (Increase) decrease in funds held by trustee.........       (416)        886
 Purchases of treasury stock..........................          -     (42,399)
 Proceeds from issuance of common stock...............     20,406       9,913
                                                        ---------   ---------

      Net cash (used in) provided by
       financing activities...........................    (54,957)     20,689
                                                        ---------   ---------

         Net increase in cash.........................     33,178      10,414

Cash and cash equivalents at beginning of period......     16,471      12,926
                                                        ---------   ---------

Cash and cash equivalents at end of period............  $  49,649   $  23,340
                                                        =========   =========




                             See accompanying notes.

                                       6


                       HEALTH MANAGEMENT ASSOCIATES, INC.
          NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Basis of Presentation
------------------------

     The condensed consolidated balance sheet as of September 30, 2000 has been
derived from the audited consolidated financial statements included in Health
Management Associates, Inc.'s (the Company's) 2000 Annual Report.  The interim
condensed consolidated financial statements at June 30, 2001 and for the three
and nine month periods ended June 30, 2001 and 2000 are unaudited; however, such
interim statements reflect all adjustments (consisting only of a normal
recurring nature) which are, in the opinion of management, necessary for a fair
presentation of the financial position and results of operations for the interim
periods presented.  The results of operations for the interim periods presented
are not necessarily indicative of the results to be expected for the full year.
The interim financial statements should be read in conjunction with the audited
consolidated financial statements of the Company included in its 2000 Annual
Report.

2.   Use of Estimates
---------------------

     The preparation of financial statements in conformity with generally
accepted accounting principles requires management of the Company to make
estimates and assumptions that affect the amounts reported in the condensed
consolidated financial statements. Actual results could differ from the
estimates.

3.  Earnings Per Share
----------------------

     The following table sets forth the computation of basic and diluted
earnings per share (in thousands, except per share data):

                                         Three months ended  Nine months ended
                                              June 30,            June 30,
                                         ------------------  ------------------
                                           2001      2000      2001      2000
                                         --------  --------  --------  --------
Numerator:
   Numerator for basic earnings per
    share-net income                     $ 54,138  $ 43,823  $143,056  $128,602
   Effect of convertible debt               1,337         -     4,010         -
                                         --------  --------  --------  --------
   Numerator for diluted earnings
    per share                            $ 55,475  $ 43,823  $147,066  $128,602
                                         ========  ========  ========  ========

Denominator:
   Denominator for basic earnings
    per share-weighted average shares     245,048   242,078   244,130   241,720
   Effect of dilutive securities:
    Employee stock options                  4,808     3,839     5,421     3,154
    Convertible debt                       14,449         -    14,449         -
                                         --------  --------  --------  --------
   Denominator for diluted earnings
    per share                             264,305   245,917   264,000   244,874
                                         ========  ========  ========  ========

Basic earnings per share                 $    .22  $    .18  $    .59  $    .53
                                         ========  ========  ========  ========
Diluted earnings per share               $    .21  $    .18  $    .56  $    .53
                                         ========  ========  ========  ========

                                       7


                      HEALTH MANAGEMENT ASSOCIATES, INC.
         NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

4.   Non-Cash Charge
--------------------

     The non-cash charge for retirement benefits and write down of assets held
for sale represents (1) the present value of the future costs of retirement
benefits granted to the Company's chairman pursuant to an employment agreement
which became effective January 2, 2001, and (2) the write down of two hospital
assets held for sale subsequent to their respective replacement.

5.   Acquisition
----------------

     Effective July 19, 2001 the Company acquired a 200-bed hospital located in
Carlisle, Pennsylvania pursuant to a Definitive Agreement and a Lease Agreement.
The consideration totaled approximately $43.2 million in cash which included
$5.1 million in net working capital and a $2.2 million prepaid lease payment.
The Company financed this transaction using available cash on hand.  The Company
is obligated to the construction of a replacement hospital, subject to obtaining
all required governmental and regulatory approvals.

6.  Recent Accounting Pronouncements
------------------------------------

     In July 2001, the Financial Accounting Standards Board issued SFAS No. 141,
Business Combinations, and SFAS No. 142, Goodwill and Other Intangible Assets.
SFAS No. 141 requires that the purchase method of accounting be used for all
business combinations initiated after June 30, 2001 as well as all purchase
method business combinations completed after June 30, 2001. SFAS No. 141 also
specifies criteria intangible assets acquired in a purchase method business
combination must meet to be recognized and reported apart from goodwill, noting
that any purchase price allocable to an assembled workforce may not be accounted
for separately. SFAS No.142 will require that goodwill and intangible assets
with indefinite useful lives no longer be amortized, but instead tested for
impairment at least annually in accordance with the provisions of SFAS No. 142.

     The Company is required to adopt the provisions of SFAS No. 141 immediately
and intends to early adopt SFAS No. 142 effective October 1, 2001. Any goodwill
and any intangible asset determined to have an indefinite useful life that is
acquired in a purchase business combination completed after June 30, 2001 will
not be amortized, but will continue to be evaluated for impairment in accordance
with the appropriate pre-SFAS No. 142 accounting literature. Goodwill and
intangible assets acquired in business combinations completed before July 1,
2001 will continue to be amortized through September 30, 2001.  For the three
and nine months ended June 30, 2001, the Company recognized $2.1 million and
$6.3 million of goodwill amortization, respectively.

                                       8


Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations

       Results of Operations
       ---------------------
       Three months ended June 30, 2001 compared
       -----------------------------------------
       to three months ended June 30, 2000
       -----------------------------------

            Net patient service revenue for the three months ended June 30, 2001
       ("2001 Period") was $473.2 million as compared to $391.1 million for the
       three months ended June 30, 2000 ("2000 Period").  This represented an
       increase in net patient service revenue of $82.1 million or 21.0%.
       Hospitals in operation for the entire 2001 Period and 2000 Period ("same
       hospitals") provided $36.7 million of the increase in net patient service
       revenue, resulting primarily from patient volume increases.  The
       remaining increase of $45.4 million included $45.6 million of net patient
       service revenue from the July 2000 acquisition of a 268-bed hospital, the
       September 2000 acquisition of a 120-bed hospital and the October 2000
       acquisition of a 149-bed hospital, offset by  a decrease of $.2 million
       in Corporate and other revenue.

            During the 2001 Period the Company's hospitals generated total
       patient days of service and an occupancy rate of 216,296 and 47.6%,
       respectively, versus 187,273 and 45.3%, respectively, for the 2000
       Period. Same hospital patient days and occupancy for the 2001 Period were
       185,146 and 47.1%, respectively, versus 172,926 and 43.5%, respectively
       for the 2000 Period.  Same hospital admissions for the Company during the
       2001 Period were 41,182, up 6.7% from the 38,609 admissions during the
       2000 Period.

            The Company's operating expenses (salaries and benefits, supplies
       and other, provision for doubtful accounts and rent expense) for the 2001
       Period were $ 356.7 million or 75.4% of net patient service revenue as
       compared to $293.1 million or 74.9% of net patient service revenue for
       the 2000 Period.  Of the total $63.6 million increase, approximately $
       25.5 million related to same hospitals, which was largely attributable to
       increased patient volumes.  Another $36.7 million of increased operating
       expense related to the acquisitions mentioned previously.  The remaining
       increase of $1.4 million represented the net increase in Corporate and
       other operating expenses.

            The Company's depreciation and amortization costs increased by $3.8
       million and interest expense decreased by $2.3 million.  The increase in
       depreciation and amortization resulted primarily from the acquisitions
       mentioned previously.  The decrease in interest expense was due to
       improved interest rates on borrowings in the 2001 period.

              The Company's income before income taxes was $89.2 million for the
       2001 Period as compared to $72.1 million for the 2000 Period, an increase
       of $17.1 million or 23.7%.  The increase resulted primarily from same
       hospital volume increases and the acquisitions mentioned previously. The
       Company's provision for income taxes was $35.0 million for the 2001
       Period as compared to $28.3 million for the 2000 Period. These provisions
       reflect effective income tax rates of approximately 39.3% for both
       periods.  As a result of the foregoing, the Company's net income was
       $54.1 million for the 2001 Period as compared to $43.8 million for the
       2000 Period.

                                       9


Item 2.  Management's discussion and Analysis of Financial
         Condition and Results of Operations (continued)


     Results of Operations
     ---------------------
     Nine months ended June 30, 2001 compared
     ----------------------------------------
     to nine months ended June 30, 2000
     ----------------------------------

            Net patient service revenue for the nine months ended June 30, 2001
     ("2001 Nine Month Period") was $1,388.6 million, as compared to $1,169.8
     million for the nine months ended June 30, 2000 ("2000 Nine Month Period").
     This represented an increase in net patient service revenue of $218.8
     million, or 18.7%.  Same hospitals provided $92.3 million of the increase
     in net patient service revenue, resulting primarily from patient volume
     increases. The remaining increase of $126.5 million included $129.1 million
     of net patient service revenue from the acquisitions mentioned previously,
     offset by a decrease of $2.6 million in Corporate and other revenue.

            During the 2001 Nine Month Period the Company's hospitals generated
      664,562 total patient days of service and an occupancy rate of 48.4%,
      respectively, versus 595,296 and 47.0%, respectively, for the 2000 Nine
      Month Period.  Same hospital patient days and occupancy for the 2001 Nine
      Month Period were 569,915 and 47.8%, respectively, versus 551,708 and
      46.0%, respectively, for the 2000 Nine Month Period.  Same hospital
      admissions for the Company during the 2001 Nine Month Period were 126,359
      up 5.0% from the 120,299 admissions during the 2000 Nine Month Period.

            The Company's operating expenses (salaries and benefits, supplies
      and other, provision for doubtful accounts and rent expense) for the 2001
      Nine Month Period were $1,053.8 million, or 75.9% of net patient service
      revenue as compared to $883.4 million or 75.5% of net patient service
      revenue for the 2000 Nine Month Period.  Of the total $170.4 million
      increase, approximately $63.3 million related to same hospitals, which was
      largely attributable to increased patient volumes.  Another $104.8 million
      of increased operating expenses related to the hospital acquisitions
      mentioned previously.  The remaining increase of $2.3 million represented
      the net increase in Corporate and other operating expenses.

            The Company's depreciation and amortization costs increased by $10.7
      million and interest expense decreased by $3.1 million. The increase in
      depreciation and amortization resulted primarily from the acquisitions
      previously mentioned.  The decrease in interest expense was due to
      improved interest rates on borrowings and increased investment income
      (which is netted against interest expense) in the 2001 Nine Month Period.
      The non-cash charge for retirement benefits and write down of assets held
      for sale represents (1) the present value of the future costs of
      retirement benefits granted to the Company's chairman pursuant to an
      employment agreement which became effective January 2, 2001, and (2) the
      write down of two hospital assets held for sale subsequent to their
      respective replacement.

                                       10


Item 2.   Management's Discussion and Analysis of Financial
          Condition and Results of Operations (Continued)

            The Company's income before income taxes was $235.5 million for the
      2001 Nine Month Period.   Excluding the non-recurring charge for
      retirement benefits and write down of assets held for sale of $17.0
      million, income before income taxes was $252.5 for the 2001 Nine Month
      Period as compared to $211.7 million for the 2000 Nine Month Period, an
      increase of $40.8 million, or 19.3%.  The increase resulted primarily from
      same hospital volume increases and the acquisitions mentioned previously.
      The Company's provision for income taxes was $92.5 million for the 2001
      Nine Month Period as compared to $83.1 million for the 2000 Nine Month
      Period. These provisions reflect effective income tax rates of
      approximately 39.3% for both periods.  As a result of the foregoing, the
      Company's net income was $143.1 million for the 2001 Nine Month Period
      including the aforementioned charge, and $153.4 for the 2001 Nine Month
      Period excluding the charge, as compared to $128.6 million for the 2000
      Nine Month Period.

      Liquidity and Capital Resources
      -------------------------------

            2001 Nine Month Period Cash Flows compared to 2000 Nine Month Period
      Cash Flows

            The Company's operating cash flows totaled $212.6 million for the
      2001 Nine Month Period as compared to $132.4 million for the 2000 Nine
      Month Period.  The continued positive cash flows from operating activities
      results from the Company's profitability and management of its working
      capital.  The Company's investing activities used $124.4 million and
      $142.7 million for the 2001 Nine Month Period and 2000 Nine Month Period,
      respectively. Construction costs related to the replacement of existing
      hospitals and acquisitions accounted for the majority of the expenditures
      in the 2000 Nine Month Period while acquisitions and ongoing renovation
      and capital equipment costs accounted for the majority of the expenditures
      in the 2001 Nine Month Period. Financing activities used net cash of $55.0
      million for the 2001 Nine Month Period and provided $20.7 million for the
      2000 Nine Month Period. Increased principal payments on debt offset by
      proceeds from the issuance of common stock accounted for the majority of
      net cash used in the 2001 Nine Month Period, while borrowings for
      acquisitions and for the purchase of treasury stock accounted for the net
      cash provided in the 2000 Nine Month Period.  See the Condensed
      Consolidated Statements of Cash Flows for the nine months ended June 30,
      2001 and 2000 at page 6 of this Report.

      Capital Resources
      -----------------

            The Company currently has a 5-year $450 million Credit Agreement
      (the "Credit Agreement") due November 30, 2004.  The Credit Agreement is a
      term loan agreement which permits the Company to borrow under an unsecured
      revolving credit loan at any time through November 30, 2004, at which time
      the agreement terminates and all outstanding amounts become due and
      payable.  The Company may choose a Base Rate Loan (prime interest rate) or
      a Eurodollar Rate Loan (LIBOR interest rate). The interest rate for a
      Eurodollar Rate Loan is currently LIBOR plus 1.00 percent (4.76% at June
      30, 2001), and will increase or decrease in relation to a change in the
      Company's credit rating.  Under either alternative, quarterly interest
      payments are required.  As of June 30, 2001, the outstanding balance was
      $65 million.

                                       11


Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations (Continued)



            The Company also has a $15 million unsecured revolving credit
       commitment with a bank.  The $15 million credit is a working capital
       commitment which is tied to the Company's cash management system, and
       renews annually on November 1.  Currently, interest on any outstanding
       balance is payable monthly at a fluctuating rate not to exceed the bank's
       prime rate less .25%.  As of June 30, 2001, there were no amounts
       outstanding under this credit commitment.

            On August 16, 2000, the Company sold $488.8 million face value of
       zero-coupon convertible senior subordinated debentures for gross proceeds
       of $287.7 million.  The debentures mature on August 16, 2020 unless
       converted or redeemed earlier.  The debentures are convertible into the
       Company's class A common stock at a conversion rate of 29.5623 shares for
       each $1,000 principal amount of debentures converted (equivalent to a
       conversion price of $19.9125 per share). Interest on the debentures is
       payable in arrears on August 16 and February 16 of each year, beginning
       February 16, 2001 at a rate of .25% per year on the principal amount due
       at maturity.  The rate of cash interest and accrual of original issue
       discount represent a yield to maturity of 3% per year, calculated from
       August 16, 2000.  The Company used the net proceeds generated from the
       sale and issuance of the debentures to pay down borrowings under its
       revolving credit facility.

            Neither the debentures nor the shares of class A common stock
       underlying the debentures were registered or required to be registered
       under the Securities Act of 1933 and were sold in the United States in a
       private placement under Rule 144A of the Securities Act.  Pursuant to a
       Registration Rights Agreement with the holders of the debentures, the
       Company registered the debentures and the underlying class A common stock
       for resale under the Securities Act pursuant to a registration statement
       on Form S-3, which registration statement became effective with the
       Securities and Exchange Commission on January 17, 2001.

            Effective July 19, 2001 the Company acquired a 200-bed hospital
       located in Carlisle, Pennsylvania pursuant to a Definitive Agreement and
       a Lease Agreement.  The consideration totaled approximately $43.2 million
       in cash.  The Company financed this transaction using available cash on
       hand.  See also footnote #5 of the Notes to Interim Condensed
       Consolidated Financial Statements at Page 8 of this Report.

              At the present time, the Company anticipates that cash on hand,
       internally generated funds, and funds available under its Credit
       Facilities will be sufficient to satisfy the Company's requirements for
       capital expenditures, future acquisitions and working capital.

                                       12


Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations (Continued)


       Forward-Looking Statements
       --------------------------

            Certain statements contained in this Form 10-Q, including, without
       limitation, statements containing the words "believes," "anticipates,"
       "intends," " expects" and words of similar import, constitute "forward-
       looking statements" within the meaning of the Private Securities
       Litigation Reform Act of 1995.  Such forward-looking statements involve
       known and unknown risks, uncertainties and other factors that may cause
       the actual results, performance or achievements of the Company or
       industry results to be materially different from any future results,
       performance or achievements expressed or implied by such forward-looking
       statements. Such factors include, among others, the following:  general
       economic and business conditions, both nationally and in the regions in
       which the Company operates; industry capacity; demographic changes;
       existing governmental regulations and changes in, or the failure to
       comply with, governmental regulations; legislative proposals for health
       care reform; the ability to enter into managed care proposals for health
       care reform; the ability to enter into Medicare and Medicaid payment
       levels; liability and other claims asserted against the Company;
       competition; the loss of any significant ability to attract and retain
       qualified personnel, including physicians; the availability and terms of
       capital to fund additional acquisitions or replacement facilities. Given
       these uncertainties, prospective investors are cautioned not to place
       undue reliance on such forward-looking statements.  The Company disclaims
       any obligation to update any such factors or to publicly announce the
       results of any revision to any of the forward-looking statements
       contained herein to reflect future events or developments.

                                       13


                          PART II - OTHER INFORMATION


Item 1.  Legal Proceedings.
         -----------------

         None.


Item 2.  Changes in Securities.
         ---------------------

         None.


Item 3.  Defaults upon Senior Securities.
         -------------------------------

         None.


Item 4.  Submission of Matters to a Vote of Security Holders.
         ---------------------------------------------------

         None.

Item 5.  Other Information.
         -----------------

         Effective July 19, 2001 the Company acquired a 200-bed hospital
         located in Carlisle, Pennsylvania pursuant to a Definitive Agreement
         and a Lease Agreement. The consideration totaled approximately $43.2
         million in cash which included $5.1 million in net working capital and
         a $2.2 million prepaid lease payment. The Company financed this
         transaction using available cash on hand. The Company is obligated to
         the construction of a replacement hospital, subject to obtaining all
         required governmental and regulatory approvals.

Item 6.  Exhibits and Reports on Form 8-K.
         --------------------------------

         a.  Exhibits:
             --------

             See Index to Exhibits located on page 16.

         b.  Reports on Form 8-K:
             -------------------

             None

                                       14


                                   SIGNATURES



    Pursuant to the requirements of the securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned, thereunto duly authorized.



                                         HEALTH MANAGEMENT ASSOCIATES, INC.



DATE:  August 10, 2001                   BY:   /s/ Robert E. Farnham
                                              ------------------------------
                                              Robert E. Farnham
                                              Senior Vice President-Finance
                                              (Duly authorized officer and
                                              Principal Financial Officer)

                                       15


                                 INDEX TO EXHIBITS


(2)   Plan of acquisition, reorganization, arrangement, liquidation or
      succession.

      Not applicable.

(3)  (i)  Articles of Incorporation

     3.1   The Fifth Restated Certificate of Incorporation, previously filed and
           included as Exhibit 3.1 to the Company's Quarterly Report on Form 10-
           Q for the quarter ended June 30, 1995, is incorporated herein by
           reference.

     3.2   Certificate of Amendment to Fifth Restated Certificate of
           Incorporation, previously filed and included as Exhibit 3.2 to the
           Company's Annual Report on Form 10-K for the year ended September 30,
           1999, is incorporated herein by reference.

     (ii)  By-laws

           The By-laws, as amended, previously filed and included as Exhibit 3.3
           to the Company's Quarterly Report on Form 10-Q for the quarter ended
           March 31, 2001, is incorporated herein by reference.

(4)  Instruments defining the rights of security holders, including indentures.

     The Exhibits referenced under (3) of this Index to Exhibits are
     incorporated herein by reference.

     Credit Agreement by and among Health Management Associates, Inc., as
     Borrower, Bank of America, N.A., as Administrative Agent and as Lender,
     First Union National Bank, as Syndication Agent and as Lender, and the
     Chase Manhattan Bank, as Syndication Agent and as Lender, and The Lenders
     Party Hereto From Time To Time, dated November 30, 1999, previously filed
     and included as Exhibit 4.5 to the Company's Annual Report on Form 10-K for
     the fiscal year ended September 30, 1999, is incorporated herein by
     reference.

     Credit Agreement dated March 23, 2000 between First Union National Bank and
     Health Management Associates, Inc., pertaining to a $15 million working
     capital and cash management line of credit, previously filed and included
     as Exhibit 4.1 to the Company's Quarterly Report on Form 10-Q for the
     quarter ended June 30, 2000, is incorporated herein by reference.

(10) Material contracts.

     Not applicable.

                                       16


                          INDEX TO EXHIBITS (Continued)



(11) Statement re computation of per share earnings.

     Not applicable.

(15) Letter re unaudited interim financial information.

     Not applicable.

(18) Letter re change in accounting principles.

     Not applicable.

(19) Report furnished to security holders.

     Not applicable.

(22) Published report regarding matters submitted to vote of security holders.

     Not applicable.

(23) Consents of experts and counsel.

     Not applicable.

(24) Power of attorney.

     Not applicable.

(99) Additional exhibits.

     Not applicable.

                                       17